Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
0.0%
operating margin TTM
0.0%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -18.59 |
| peg ratio | -0.67 |
| price to book ratio | -270.64 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -1.31 |
| price fair value | -270.64 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -404.01% |
| return on equity | -1197.81% |
| return on capital employed | 1572.16% |
liquidity ratios | |
|---|---|
| current ratio | 0.75 |
| quick ratio | 0.75 |
| cash ratio | 0.51 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 88,104.05 |
| cash conversion cycle | -88,104.05 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | -0.10 |
| long term debt to capitalization | -0.02 |
| total debt to capitalization | -0.11 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -125.45 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.06 |
| cash per share | 0.01 |
| operating cash flow per share | -0.06 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -125.45 |
| short term coverage ratios | -182.57 |
| capital expenditure coverage ratio | -532.96 |
Frequently Asked Questions
When was the last time Immunic, Inc. (NASDAQ:IMUX) reported earnings?
Immunic, Inc. (IMUX) published its most recent earnings results on 13-11-2025.
What is Immunic, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Immunic, Inc. (NASDAQ:IMUX)'s trailing twelve months ROE is -1197.81%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Immunic, Inc. (IMUX) currently has a ROA of -404.01%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IMUX's net profit margin stand at?
IMUX reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IMUX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.75 in the most recent quarter. The quick ratio stood at 0.75, with a Debt/Eq ratio of -0.10.